Correlation Between Mineralys Therapeutics, and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Mineralys Therapeutics, and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Zentalis Pharmaceuticals.
Diversification Opportunities for Mineralys Therapeutics, and Zentalis Pharmaceuticals
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Zentalis is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.53 times more return on investment than Zentalis Pharmaceuticals. However, Mineralys Therapeutics, Common is 1.88 times less risky than Zentalis Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.07 per unit of risk. If you would invest 1,308 in Mineralys Therapeutics, Common on August 31, 2024 and sell it today you would lose (31.00) from holding Mineralys Therapeutics, Common or give up 2.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Zentalis Pharmaceuticals |
Mineralys Therapeutics, and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Zentalis Pharmaceuticals
The main advantage of trading using opposite Mineralys Therapeutics, and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Mineralys Therapeutics, vs. Cue Biopharma | Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Inhibrx | Mineralys Therapeutics, vs. Molecular Partners AG |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |